Constantine Davides
Stock Analyst at Citizens
(1.01)
# 3,874
Out of 5,055 analysts
114
Total ratings
29.52%
Success rate
-19.74%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Market Outperform | $13 → $11 | $4.18 | +163.16% | 11 | Nov 10, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.45 | +32.20% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $15.20 | +57.89% | 11 | Nov 7, 2025 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $15.89 | +51.04% | 12 | Nov 7, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $38 → $36 | $28.41 | +26.72% | 7 | Oct 31, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $35.32 | +35.90% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $108.90 | +37.74% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $17.31 | - | 2 | Jun 18, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $110 → $117 | $101.77 | +14.97% | 5 | Jun 4, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $8.33 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.58 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $71.67 | +57.67% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $23.54 | +10.47% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $183.59 | +35.08% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $24.47 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $11.14 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.55 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.42 | +269.72% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.68 | +18,236.51% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $25.27 | -40.64% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $22.25 | +1.12% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.13 | +171.57% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.19 | +1,076.47% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $3.00 | +11,900.00% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.60 | +202,400.00% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.72 | +5,471.81% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.33 | +1,712.14% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.50 | +53,233.33% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $2.09 | +238,177.51% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.63 | +13,445.82% | 2 | Sep 23, 2022 |
Evolent Health
Nov 10, 2025
Maintains: Market Outperform
Price Target: $13 → $11
Current: $4.18
Upside: +163.16%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.45
Upside: +32.20%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $15.20
Upside: +57.89%
AMN Healthcare Services
Nov 7, 2025
Maintains: Market Outperform
Price Target: $22 → $24
Current: $15.89
Upside: +51.04%
Option Care Health
Oct 31, 2025
Maintains: Market Outperform
Price Target: $38 → $36
Current: $28.41
Upside: +26.72%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $35.32
Upside: +35.90%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $108.90
Upside: +37.74%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $17.31
Upside: -
HealthEquity
Jun 4, 2025
Maintains: Market Outperform
Price Target: $110 → $117
Current: $101.77
Upside: +14.97%
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.33
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.58
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $71.67
Upside: +57.67%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $23.54
Upside: +10.47%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $183.59
Upside: +35.08%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $24.47
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.14
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $24.55
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.42
Upside: +269.72%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.68
Upside: +18,236.51%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $25.27
Upside: -40.64%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $22.25
Upside: +1.12%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.13
Upside: +171.57%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.19
Upside: +1,076.47%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $3.00
Upside: +11,900.00%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.60
Upside: +202,400.00%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.72
Upside: +5,471.81%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.33
Upside: +1,712.14%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.50
Upside: +53,233.33%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $2.09
Upside: +238,177.51%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.63
Upside: +13,445.82%